National Health (Pharmaceutical Benefits Early Supply) Amendment Instrument 2015 (No. 5) specification under subsection 84AAA(2) (PB 57 of 2015) (Cth)
PB 57 of 2015
National Health (Pharmaceutical Benefits – Early Supply) Amendment Instrument 2015 (No. 5) – specification under subsection 84AAA(2)
National Health Act 1953
I, FELICITY McNEILL, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.
Dated 26 June 2015
FELICITY McNEILL
First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health
___________________________________________________________________________
Amendment determination – Pharmaceutical Benefits – Early Supply
1 Name of Instrument
(1) This Instrument is the National Health (Pharmaceutical Benefits – Early Supply) Amendment Instrument 2015 (No. 5) – specification under subsection 84AAA(2).
(2)This Instrument may also be cited as PB 57 of 2015.
2 Commencement
This Instrument commences on 1 July 2015.
3 Amendment of PB 30 of 2009
Schedule 1 amends the National Health (Pharmaceutical Benefits – Early Supply) Instrument 2009 – specification under subsection 84AAA(2) (PB 30 of 2009).
Schedule 1 Amendments
Schedule 1, entry for Esomeprazole
substitute:
| Esomeprazole | Capsule (enteric) 20 mg (as magnesium) | Oral | 30 | 1 |
| Capsule (enteric) 20 mg (as magnesium) | Oral | 30 | 5 | |
| Capsule (enteric) 40 mg (as magnesium) | Oral | 30 | 1 | |
| Capsule (enteric) 40 mg (as magnesium) | Oral | 30 | 5 | |
| Tablet (enteric coated) 20 mg (as magnesium trihydrate) | Oral | 30 | 5 | |
| Tablet (enteric coated) 40 mg (as magnesium trihydrate) | Oral | 30 | 5 |
0
0
0